These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20652858)

  • 1. Characteristics and clinical changes during hospitalization in bipolar and psychotic disorder patients with versus without substance-use disorders.
    Vincenti A; Ventriglio A; Baldessarini RJ; Talamo A; Fitzmaurice G; Centorrino F
    Pharmacopsychiatry; 2010 Aug; 43(6):225-32. PubMed ID: 20652858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential clinical characteristics, medication usage, and treatment response of bipolar disorder in the US versus The Netherlands and Germany.
    Post RM; Leverich GS; Altshuler LL; Frye MA; Suppes T; Keck PE; McElroy SL; Nolen WA; Kupka R; Grunze H; Walden J; Rowe M
    Int Clin Psychopharmacol; 2011 Mar; 26(2):96-106. PubMed ID: 21178634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
    Lee JH; Dunner DL
    Depress Anxiety; 2008; 25(2):91-7. PubMed ID: 17311265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of substance abuse on hallucination rates and treatment responses in chronic psychiatric patients.
    Sokolski KN; Cummings JL; Abrams BI; DeMet EM; Katz LS; Costa JF
    J Clin Psychiatry; 1994 Sep; 55(9):380-7. PubMed ID: 7929017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up.
    Mazza M; Mandelli L; Di Nicola M; Harnic D; Catalano V; Tedeschi D; Martinotti G; Colombo R; Bria P; Serretti A; Janiri L
    J Affect Disord; 2009 May; 115(1-2):27-35. PubMed ID: 18845344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].
    Verdoux H; Mury M; Besançon G; Bourgeois M
    Encephale; 1996; 22(2):95-101. PubMed ID: 8706627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of medication adherence in a cohort of patients with bipolar disorder.
    González-Pinto A; Reed C; Novick D; Bertsch J; Haro JM
    Pharmacopsychiatry; 2010 Nov; 43(7):263-70. PubMed ID: 20842617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline characteristics and outcomes in patients with first episode or multiple episodes of acute mania.
    Tohen M; Vieta E; Gonzalez-Pinto A; Reed C; Lin D;
    J Clin Psychiatry; 2010 Mar; 71(3):255-61. PubMed ID: 19709503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anxiety disorders in 318 bipolar patients: prevalence and impact on illness severity and response to mood stabilizer.
    Henry C; Van den Bulke D; Bellivier F; Etain B; Rouillon F; Leboyer M
    J Clin Psychiatry; 2003 Mar; 64(3):331-5. PubMed ID: 12716276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbid anxiety disorders and divalproex sodium use among partial hospital patients with psychotic disorders.
    Townsend MH; Wilson MS
    Compr Psychiatry; 2005; 46(5):368-70. PubMed ID: 16122537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychiatric comorbidity in older adults with bipolar disorder.
    Sajatovic M; Blow FC; Ignacio RV
    Int J Geriatr Psychiatry; 2006 Jun; 21(6):582-7. PubMed ID: 16783798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with pharmacologic noncompliance in patients with mania.
    Keck PE; McElroy SL; Strakowski SM; Stanton SP; Kizer DL; Balistreri TM; Bennett JA; Tugrul KC; West SA
    J Clin Psychiatry; 1996 Jul; 57(7):292-7. PubMed ID: 8666570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological treatment of psychiatric comorbidity in bipolar disorder: a review of controlled trials.
    Singh JB; Zarate CA
    Bipolar Disord; 2006 Dec; 8(6):696-709. PubMed ID: 17156156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and impact of comorbid anxiety and bipolar disorder.
    Keller MB
    J Clin Psychiatry; 2006; 67 Suppl 1():5-7. PubMed ID: 16426110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attrition factors in clinical trials of comorbid bipolar and substance-related disorders.
    Nomamiukor N; Brown ES
    J Affect Disord; 2009 Jan; 112(1-3):284-8. PubMed ID: 18511129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: a pilot study.
    Brady KT; Sonne SC; Anton R; Ballenger JC
    J Clin Psychiatry; 1995 Mar; 56(3):118-21. PubMed ID: 7883730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical antipsychotics in bipolar and schizoaffective disorders.
    Brown ES; Thomas NR; Carmody T; Mahadi S; Nejtek VA
    Pharmacopsychiatry; 2001 Mar; 34(2):80-1. PubMed ID: 11302568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbidity in bipolar disorder: a framework for rational treatment selection.
    McIntyre RS; Konarski JZ; Yatham LN
    Hum Psychopharmacol; 2004 Aug; 19(6):369-86. PubMed ID: 15303241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and distinct correlates of anxiety, substance, and combined comorbidity in a multi-site public sector sample with bipolar disorder.
    Bauer MS; Altshuler L; Evans DR; Beresford T; Williford WO; Hauger R;
    J Affect Disord; 2005 Apr; 85(3):301-15. PubMed ID: 15780700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recorded psychiatric comorbidity with bipolar disorder--a Finnish hospital discharge register study.
    Sorvaniemi M; Hintikka J
    Nord J Psychiatry; 2005; 59(6):531-3. PubMed ID: 16316909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.